260 related articles for article (PubMed ID: 21102585)
1. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development.
Avruch J; Zhou D; Fitamant J; Bardeesy N
Br J Cancer; 2011 Jan; 104(1):24-32. PubMed ID: 21102585
[TBL] [Abstract][Full Text] [Related]
2. Hippo pathway regulation of gastrointestinal tissues.
Yu FX; Meng Z; Plouffe SW; Guan KL
Annu Rev Physiol; 2015; 77():201-27. PubMed ID: 25293527
[TBL] [Abstract][Full Text] [Related]
3. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.
Wu H; Wei L; Fan F; Ji S; Zhang S; Geng J; Hong L; Fan X; Chen Q; Tian J; Jiang M; Sun X; Jin C; Yin ZY; Liu Q; Zhang J; Qin F; Lin KH; Yu JS; Deng X; Wang HR; Zhao B; Johnson RL; Chen L; Zhou D
Nat Commun; 2015 Feb; 6():6239. PubMed ID: 25695629
[TBL] [Abstract][Full Text] [Related]
4. Role of the transcriptional coactivators YAP/TAZ in liver cancer.
Zhang S; Zhou D
Curr Opin Cell Biol; 2019 Dec; 61():64-71. PubMed ID: 31387016
[TBL] [Abstract][Full Text] [Related]
5. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
6. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
7. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.
Lu L; Finegold MJ; Johnson RL
Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509
[TBL] [Abstract][Full Text] [Related]
8. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
Werneburg N; Gores GJ; Smoot RL
Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
[TBL] [Abstract][Full Text] [Related]
9. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
[TBL] [Abstract][Full Text] [Related]
10. YAP and TAZ: a nexus for Hippo signaling and beyond.
Hansen CG; Moroishi T; Guan KL
Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
[TBL] [Abstract][Full Text] [Related]
11. [Hippo-YAP signaling pathway in the liver: more than a size gatekeeper!].
Gilgenkrantz H
Med Sci (Paris); 2011 May; 27(5):479-81. PubMed ID: 21609667
[No Abstract] [Full Text] [Related]
12. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.
Gao T; Zhou D; Yang C; Singh T; Penzo-Méndez A; Maddipati R; Tzatsos A; Bardeesy N; Avruch J; Stanger BZ
Gastroenterology; 2013 Jun; 144(7):1543-53, 1553.e1. PubMed ID: 23454691
[TBL] [Abstract][Full Text] [Related]
13. [Research advances in the role of the Hippo-YAP/TAZ signaling pathway in primary liver cancer].
Guo LW; Shao GL
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):878-880. PubMed ID: 29325286
[TBL] [Abstract][Full Text] [Related]
14. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.
Kowalik MA; Saliba C; Pibiri M; Perra A; Ledda-Columbano GM; Sarotto I; Ghiso E; Giordano S; Columbano A
Hepatology; 2011 Jun; 53(6):2086-96. PubMed ID: 21391223
[TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.
Mannaerts I; Leite SB; Verhulst S; Claerhout S; Eysackers N; Thoen LF; Hoorens A; Reynaert H; Halder G; van Grunsven LA
J Hepatol; 2015 Sep; 63(3):679-88. PubMed ID: 25908270
[TBL] [Abstract][Full Text] [Related]
16. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
Lin C; Yao E; Chuang PT
Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
[TBL] [Abstract][Full Text] [Related]
17. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
18. Hippo signaling in the kidney: the good and the bad.
Wong JS; Meliambro K; Ray J; Campbell KN
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F241-8. PubMed ID: 27194720
[TBL] [Abstract][Full Text] [Related]
19. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
20. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease.
He J; Bao Q; Yan M; Liang J; Zhu Y; Wang C; Ai D
Br J Pharmacol; 2018 Apr; 175(8):1354-1361. PubMed ID: 28369744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]